389 related articles for article (PubMed ID: 11471764)
1. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Lindenbaum Y; Kissel JT; Mendell JR
Neurol Clin; 2001 Feb; 19(1):187-204. PubMed ID: 11471764
[TBL] [Abstract][Full Text] [Related]
2. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Guillain-Barré syndrome and CIDP.
van Doorn PA
J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
[TBL] [Abstract][Full Text] [Related]
4. Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Querol L; Lleixà C
Neurotherapeutics; 2021 Oct; 18(4):2222-2235. PubMed ID: 34549385
[TBL] [Abstract][Full Text] [Related]
5. Treatment of immune-mediated inflammatory neuropathies.
Hadden RD; Hughes RA
Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
[TBL] [Abstract][Full Text] [Related]
6. Acquired inflammatory demyelinating neuropathies.
Ensrud ER; Krivickas LS
Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
[TBL] [Abstract][Full Text] [Related]
7. Treatment of immune neuropathies.
Van Doorn PA; Garssen MP
Curr Opin Neurol; 2002 Oct; 15(5):623-31. PubMed ID: 12352007
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Pham HP; Schwartz J
Presse Med; 2019 Nov; 48(11 Pt 2):338-346. PubMed ID: 31679897
[TBL] [Abstract][Full Text] [Related]
9. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
Mathis S; Vallat JM; Magy L
Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
[TBL] [Abstract][Full Text] [Related]
10. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Kanbayashi T; Sonoo M
Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
[TBL] [Abstract][Full Text] [Related]
11. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
Eldar AH; Chapman J
Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
[TBL] [Abstract][Full Text] [Related]
12. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated neuropathies.
Kieseier BC; Mathey EK; Sommer C; Hartung HP
Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
[TBL] [Abstract][Full Text] [Related]
14. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
Kazmi MA; Mahdi-Rogers M; Sanvito L
Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory neuropathies.
Whitesell J
Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
[TBL] [Abstract][Full Text] [Related]
17. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
Eur J Neurol; 2023 Dec; 30(12):3646-3674. PubMed ID: 37814552
[TBL] [Abstract][Full Text] [Related]
18. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
J Peripher Nerv Syst; 2023 Dec; 28(4):535-563. PubMed ID: 37814551
[TBL] [Abstract][Full Text] [Related]
19. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
[TBL] [Abstract][Full Text] [Related]
20. [Immune-mediated neuropathies].
Stoll G; Reiners K
Nervenarzt; 2016 Aug; 87(8):887-98. PubMed ID: 27474733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
